The rising role of natural killer cells in patients with malignant hematological disorders and in recipients of hematopoietic stem cell transplantation
Open Access
- 1 October 2019
- journal article
- Published by Heighten Science Publications Corporation in Journal of Stem Cell Therapy and Transplantation
- Vol. 3 (1), 023-027
- https://doi.org/10.29328/journal.jsctt.1001015
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR–ABL-positive miceLeukemia, 2011
- Natural Killer Cell Education and ToleranceCell, 2010
- Natural Killer Cells in Allogeneic Transplantation: Effect on Engraftment, Graft- versus-Tumor, and Graft-versus-Host ResponsesTransplantation and Cellular Therapy, 2009
- Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantationBritish Journal of Haematology, 2008
- Role of Natural Killer Cells in Modulating Dendritic Cell Responses toLeishmania amazonensisInfectionInfection and Immunity, 2008
- Interactions Between Human Mesenchymal Stem Cells and Natural Killer CellsThe International Journal of Cell Cloning, 2005
- Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myelomaBritish Journal of Haematology, 2005
- Natural killer cells and dendritic cells: rendezvous in abused tissuesNature Reviews Immunology, 2002
- Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer CellsThe Journal of Experimental Medicine, 2002
- Reciprocal Activating Interaction between Natural Killer Cells and Dendritic CellsThe Journal of Experimental Medicine, 2002